5/11/2009

A Phase III study involving early-stage breast cancer patients showed that the radiopharmaceutical Lymphoseek can detect 100% of cancer-positive lymph nodes quicker and in a more convenient and targeted way than standard methods. "These results will really enable molecular biology to enter the operating room for lymph node detection," a researcher said.

Full Story:
ScienceDaily

Related Summaries